← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Nous Biosciences Inc
Doylestown, PA
$757,412
Total funding
2
Grants
Funding over time
peak $448.8K · FY2024–25$500K$375K$250K$125K$0
'24
'25
Funding mix
By agency
NIH$757,412 · 2
By mechanism
R43$757,412 · 2
Investigators at Nous Biosciences Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Combination of formulated dolcanatide, a guanylate cyclase-C agonist, with formulated atiprimod, a JAK-STAT inhibitor, for treatment of murine colitis.$358,039
R43 · FY2025 · DK
Microsphere-based formulation of dolcanatide to prevent colon carcinogenesis$308,650
R43 · FY2024 · CA
Microsphere-based formulation of dolcanatide to prevent colon carcinogenesis$90,723
R43 · FY2025 · CA